British Journal of General Practice · 2019 · 24 citations · 16 references
PharmacyCardiologyClinical PharmacologyMass Spectrometric AnalysisPharmaceutical ComplianceBlood Pressure ManagementHypertension ControlHypertension ManagementMedication AdherencePatient AdherenceAdherenceAdherence MeasurementAdherence To Antihypertensive TherapyAntihypertensive Medication AdherenceBlood PressureFeasibility Study DesignMedication Adherence AnalysisTreatment-resistant Hypertension
BACKGROUND: Apparent treatment-resistant hypertension (aTRH) is defined as uncontrolled blood pressure (BP) in patients taking three or more antihypertensive medications. Some patients will have true treatment-resistant hypertension, some undiagnosed secondary hypertension, while others have pseudo-resistance. Pseudo-resistance occurs when non-adherence to medication, white-coat hypertension (WCH), lifestyle, and inadequate drug dosing are responsible for the poorly controlled BP. AIM: To examine the feasibility of establishing non-adherence to medication, for the first time in primary care, using mass spectrometry urine analysis. Operationalisation would be established by at least 50% of patients participating and 95% of samples being suitable for analysis. Clinical importance would be confirmed by >10% of patients being non-adherent. DESIGN AND SETTING: = 453) in 15 university research-affiliated Irish general practices were invited to participate. METHOD: Participants underwent mass spectrometry urine analysis to test adherence and ambulatory BP monitoring (ABPM) to examine WCH. RESULTS: = 235) participated. All 235 urine samples (100%) were suitable for analysis: 174 (74%) patients were fully adherent, 56 (24%) partially adherent, and five (2%) fully non-adherent to therapy. A total of 206 patients also had ABPM, and in total 92 (45%) were categorised as pseudo-resistant. No significant associations were found between adherence status and patient characteristics or drug class. CONCLUSION: In patients with aTRH, the authors have established that it is feasible to examine non-adherence to medications using mass spectrometry urine analysis. One in four patients were found to be partially or fully non-adherent. Further research on how to incorporate this approach into individual patient consultations and its associated cost-effectiveness is now appropriate.
16
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · European Heart Journal · 2013 · 13.7K citations · Full text
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz et al. · Journal of Hypertension · 2013 · 5.7K citations
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
David A. Calhoun, Daniel Jones, Stephen C. Textor et al. · Circulation · 2008 · 2.2K citations · Full text
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
David A. Calhoun, Daniel Jones, Stephen C. Textor et al. · Hypertension · 2008 · 1.4K citations